Advanced search
Publication Cover
Leukemia & Lymphoma Volume 45, 2004 - Issue 1
Submit an article Journal homepage
15
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Lack of Prognostic Significance of BCL2 and p53 Protein Overexpression in Elderly Patients with Diffuse Large B-cell Non-Hodgkin's Lymphoma: Results from a Population-based Non-Hodgkin's Lymphoma Registry

E Maartense Department of Internal Medicine, Reinier de Graaf Gasthuis, Reinier de Graafweg 3-11, 2625 AD Delft, The NetherlandsCorrespondence[email protected]
,
MHH Kramer Department of Internal Medicine, Meander Medical Center, P.O. Box 1502, 3800 BM Amersfoort, The Netherlands
,
S le Cessie Department of Medical Statistics, Leiden University Medical Center, Wassenaarseweg 62, 2333 AL Leiden, The Netherlands
,
JC Kluin-Nelemans Department of Haematology, Academic Hospital Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands
,
PM Kluin Department of Pathology, Academic Hospital Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands
,
S Snijder Comprehensive Cancer Center West, Schipholweg 5a, 2316XB Leiden, The Netherlands
&
EM Noordijk Department of Clinical Oncology, Leiden University Medical Center, P.O.Box 9600, 2300 RC Leiden, The Netherlands
 show all
Pages 101-107 | Received 03 May 2003, Published online: 03 Aug 2009

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Roberta Soares Faccion, Lidia Maria Magalhães Rezende, Sérgio de Oliveira Romano, Ricardo de Sá Bigni, Gelcio Luiz Quintella Mendes & Raquel Ciuvalschi Maia. (2012) Centroblastic Diffuse Large B Cell Lymphoma Displays Distinct Expression Pattern and Prognostic Role of Apoptosis Resistance Related Proteins. Cancer Investigation 30:5, pages 404-414.
Read now
Douglas A. Stewart, Nizar Bahlis & Adnan Mansoor. (2009) pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantation. Leukemia & Lymphoma 50:8, pages 1276-1282.
Read now

Articles from other publishers (9)

Hui Liu, Zijun Y Xu‐Monette, Guilin Tang, Wei Wang, Young Kim, Ji Yuan, Yu Li, Weina Chen, Yanping Li, George Y Fedoriw, Feng Zhu, Xiaosheng Fang, Catherine Luedke, L Jeffrey Medeiros, Ken H Young & Shimin Hu. (2021) EBV + high‐grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a multi‐institutional study . Histopathology 80:3, pages 575-588.
Crossref
Xuan J Wang, L Jeffrey Medeiros, Carlos E Bueso-Ramos, Guilin Tang, Sa Wang, Yasuhiro Oki, Parth Desai, Joseph D Khoury, Roberto N Miranda, Zhenya Tang, Nishitha Reddy & Shaoying Li. (2017) P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma. Modern Pathology 30:2, pages 194-203.
Crossref
Anamarija M. Perry, Zdravko MitrovicWing C. Chan. (2012) Biological Prognostic Markers in Diffuse Large B-Cell Lymphoma. Cancer Control 19:3, pages 214-226.
Crossref
Vera Uzurov-Dinic, Aleksandar Savic, Tanja Lazarevic, Vesna Cemerikic-Martinovic, Danijela Agic & Stevan Popovic. (2009) Prognostic factors in patients with diffuse large B-cell lymphoma. Medicinski pregled Medical review 62:3-4, pages 171-176.
Crossref
. 2008. Cytogenetics, FISH and Molecular Testing in Hematologic Malignancies. Cytogenetics, FISH and Molecular Testing in Hematologic Malignancies 125 242 .
Deirdre P. Cronin-Fenton, Linda Sharp, Sandra Deady & Harry Comber. (2006) Treatment and survival for non-Hodgkin’s lymphoma: Influence of histological subtype, age, and other factors in a population-based study (1999–2001). European Journal of Cancer 42:16, pages 2786-2793.
Crossref
Izidore S. Lossos & Daniel Morgensztern. (2006) Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology 24:6, pages 995-1007.
Crossref
Randy D Gascoyne. (2004) Emerging prognostic factors in diffuse large B cell lymphoma. Current Opinion in Oncology 16:5, pages 436-441.
Crossref
. (2004) Current Awareness in Hematological Oncology. Hematological Oncology 22:2, pages 73-84.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.